267 related articles for article (PubMed ID: 22108196)
1. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH
Gastroenterology; 2012 Mar; 142(3):442-452.e5; quiz e22-3. PubMed ID: 22108196
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
[TBL] [Abstract][Full Text] [Related]
3. Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.
Loomans-Kropp HA; Chaloux M; Richmond E; Umar A
Cancer Prev Res (Phila); 2021 Feb; 14(2):195-204. PubMed ID: 32998939
[TBL] [Abstract][Full Text] [Related]
4. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
5. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium.
Lubin JH; Cook MB; Pandeya N; Vaughan TL; Abnet CC; Giffen C; Webb PM; Murray LJ; Casson AG; Risch HA; Ye W; Kamangar F; Bernstein L; Sharp L; Nyrén O; Gammon MD; Corley DA; Wu AH; Brown LM; Chow WH; Ward MH; Freedman ND; Whiteman DC
Cancer Epidemiol; 2012 Jun; 36(3):306-16. PubMed ID: 22504051
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
7. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
Nguyen DM; Richardson P; El-Serag HB
Gastroenterology; 2010 Jun; 138(7):2260-6. PubMed ID: 20188100
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
Khalaf N; Nguyen T; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1832-9.e6. PubMed ID: 24793026
[TBL] [Abstract][Full Text] [Related]
10. Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
Drahos J; Xiao Q; Risch HA; Freedman ND; Abnet CC; Anderson LA; Bernstein L; Brown L; Chow WH; Gammon MD; Kamangar F; Liao LM; Murray LJ; Ward MH; Ye W; Wu AH; Vaughan TL; Whiteman DC; Cook MB
Int J Cancer; 2016 Jan; 138(1):55-64. PubMed ID: 26175109
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.
Cook MB; Kamangar F; Whiteman DC; Freedman ND; Gammon MD; Bernstein L; Brown LM; Risch HA; Ye W; Sharp L; Pandeya N; Webb PM; Wu AH; Ward MH; Giffen C; Casson AG; Abnet CC; Murray LJ; Corley DA; Nyrén O; Vaughan TL; Chow WH
J Natl Cancer Inst; 2010 Sep; 102(17):1344-53. PubMed ID: 20716718
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
14. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.
Petrick JL; Li N; Anderson LA; Bernstein L; Corley DA; El Serag HB; Hardikar S; Liao LM; Liu G; Murray LJ; Rubenstein JH; Schneider JL; Shaheen NJ; Thrift AP; van den Brandt PA; Vaughan TL; Whiteman DC; Wu AH; Zhao WK; Gammon MD; Cook MB
Cancer; 2019 Dec; 125(23):4210-4223. PubMed ID: 31490550
[TBL] [Abstract][Full Text] [Related]
15. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
16. Dietary intake of lignans and risk of adenocarcinoma of the esophagus and gastroesophageal junction.
Lin Y; Yngve A; Lagergren J; Lu Y
Cancer Causes Control; 2012 Jun; 23(6):837-44. PubMed ID: 22527161
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.
Schneider JL; Zhao WK; Corley DA
Dig Dis Sci; 2015 Feb; 60(2):436-43. PubMed ID: 25213077
[TBL] [Abstract][Full Text] [Related]
18. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.
Murphy G; Kamangar F; Dawsey SM; Stanczyk FZ; Weinstein SJ; Taylor PR; Virtamo J; Abnet CC; Albanes D; Freedman ND
J Natl Cancer Inst; 2011 Jul; 103(14):1123-9. PubMed ID: 21693726
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
Epplein M; Nomura AM; Wilkens LR; Henderson BE; Kolonel LN
Am J Epidemiol; 2009 Aug; 170(4):507-14. PubMed ID: 19584132
[TBL] [Abstract][Full Text] [Related]
20. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
